541400 — Zim Laboratories Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹4.71bn
- IN₹5.16bn
- IN₹3.99bn
- 65
- 38
- 40
- 44
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4.99 | 62.2 | 108 | 116 | 64.2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 946 | 698 | 727 | 898 | 989 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,941 | 1,820 | 1,918 | 2,121 | 1,909 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,072 | 1,122 | 1,052 | 1,069 | 1,216 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 3,285 | 3,253 | 3,248 | 3,416 | 3,416 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,552 | 1,434 | 1,420 | 1,459 | 1,108 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Funded Status | |||||
Total Liabilities | 1,773 | 1,715 | 1,640 | 1,659 | 1,412 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 1,511 | 1,538 | 1,608 | 1,757 | 2,003 |
Total Liabilities & Shareholders' Equity | 3,285 | 3,253 | 3,248 | 3,416 | 3,416 |
Total Common Shares Outstanding |